Q4 2025 Oncology Institute Inc Earnings Call Transcript

Mar 12, 2026 / 09:00 PM GMT

Release Date Price: $0.055

Transcript 10-K8-K

Key Points

Positve

The Oncology Institute Inc (TOI) achieved its first profitable quarter as a public company from an adjusted EBITDA perspective.
Revenue increased approximately 28% year over year, surpassing $500 million for the first time in the company's history.
TOI expanded its capitated care model, initiating 9 new capitated contracts in 2025, covering approximately 260,000 additional patient lives.
The Part D dispensing platform contributed significantly to revenue, reaching almost $270 million and contributing close to $50 million in gross profit for the full year.
TOI strengthened its balance sheet by reducing debt on its convertible preferred note by $24 million and ended the year with $33.6 million in cash.

Negative

The Inflation Reduction Act is expected to have a minor unfavorable impact on TOI's pharmacy revenue and gross margin in 2026.
The first quarter of 2026 is anticipated to result in an adjusted EBITDA loss due to seasonal factors such as patients' deductible resets and annual drug price increases.
There is potential for a dip in profit margins in mid-2026 due to the ramp-up of capitated contracts in delegated networks.
The company does not take risks on CAR T therapies, which could limit its offerings in certain advanced treatment areas.
Fee for service revenue growth is expected to be flat to low single-digit in 2026, which is below the high single-digit growth previously anticipated.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TOI.OQ - Oncology Institute Inc
Q4 2025 Oncology Institute Inc Earnings Call
Mar 12, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Oncology Institute 4th quarter 2025 earnings call.

At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press 0 on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mark Heppelheiser, general counsel.

Thank you, sir. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
The press release announcing the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.